SNDL Inc. (SNDL)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.48
-2.32%
Mkt Cap $391.39M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | $187.86M | $183.87M | -2.12% | $0.01 | $0.03 | +200.00% | — | — |
| Q4 2025 Nov 4, 2025 | $257.97M | $175.10M | -32.12% | -$0.00 | -$0.04 | -11011.11% | — | — |
| Q3 2025 Jul 31, 2025 | $242.98M | $179.66M | -26.06% | -$0.04 | $0.01 | +125.00% | — | — |
| Q2 2025 May 1, 2025 | $243.30M | $143.89M | -40.86% | -$0.06 | -$0.04 | +33.33% | — | — |
| Q1 2025 Mar 18, 2025 | $204.10M | $179.06M | -12.27% | -$0.01 | -$0.19 | -1800.00% | — | — |
| Q4 2024 Nov 5, 2024 | $248.10M | $174.56M | -29.64% | -$0.04 | -$0.05 | -40.02% | — | — |
| Q3 2024 Aug 1, 2024 | $168.91M | $166.86M | -1.22% | -$0.04 | -$0.01 | +75.00% | — | — |
| Q2 2024 May 8, 2024 | $180.21M | $145.62M | -19.19% | -$0.04 | -$0.01 | +75.00% | — | — |
| Q1 2024 Mar 20, 2024 | $182.59M | $187.06M | +2.45% | -$0.12 | -$0.22 | -83.33% | — | — |
| Q4 2023 Nov 13, 2023 | $182.59M | $175.41M | -3.93% | $0.01 | -$0.06 | -915.22% | — | — |
| Q3 2023 Aug 14, 2023 | $182.59M | $184.58M | +1.09% | $0.01 | -$0.08 | -1161.01% | — | — |
| Q2 2023 May 15, 2023 | $175.98M | $149.62M | -14.98% | $0.01 | -$0.07 | -1047.23% | — | — |
| Q2 2023 Apr 24, 2023 | $177.56M | $179.17M | +0.91% | $0.01 | -$0.13 | -981.36% | — | — |
| Q4 2022 Nov 14, 2022 | $164.87M | $168.32M | +2.09% | -$0.00 | -$0.02 | -925.64% | — | — |
| Q3 2022 Aug 12, 2022 | $161.30M | $173.67M | +7.67% | -$0.01 | -$0.08 | -985.48% | — | — |
| Q2 2022 May 16, 2022 | $16.19M | $14.08M | -13.05% | — | -$0.20 | — | — | — |
| Q2 2022 Apr 27, 2022 | $13.84M | $17.82M | +28.78% | -$0.05 | -$0.20 | -300.00% | — | — |
| Q4 2021 Nov 11, 2021 | — | $11.33M | — | — | $0.10 | — | — | — |
| Q3 2021 Aug 12, 2021 | $9.15M | $7.38M | -19.32% | — | $0.10 | — | — | — |
| Q2 2021 May 11, 2021 | — | $7.87M | — | — | -$0.70 | — | — | — |